All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Soluble *N*-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins, including target- (t-) membrane SNAREs (Syntaxins \[Syn\]) and synaptosomal-associated proteins of 25 kDa (SNAP25) and vesicle-associated membrane proteins (VAMPs), are the fundamental components of the exocytotic machinery required for the docking and fusion of secretory granules (SGs) with the plasma membrane (PM), which have been well studied in neurons \[[@pone.0147862.ref001], [@pone.0147862.ref002]\] and neuroendocrine cells, particularly pancreatic islet β-cells \[[@pone.0147862.ref003]--[@pone.0147862.ref005]\]. t-SNAREs Syn-1A and SNAP25 through their interactions with PM-bound voltage-gated calcium channels (Ca~v~), L-type in β-cells and N-type in neurons, position the predocked SGs to the site of maximum Ca^2+^ influx for efficient exocytosis \[[@pone.0147862.ref006]--[@pone.0147862.ref012]\].

Ca~v~s regulate secretion in neurons and β-cells \[[@pone.0147862.ref013], [@pone.0147862.ref014]\]. Ca~v~α1 pore-forming subunits, Ca~v~1 and Ca~v~2, exist as heteromeric complexes by association with auxiliary subunits, β and α~2~δ subunits, which mediate trafficking of Ca~v~s to the PM and fine-tune their biophysical properties \[[@pone.0147862.ref013], [@pone.0147862.ref014]\]. In β-cells, L-type Ca~v~1s (Ca~v~1.2 is abundant in rodents; Ca~v~1.3 is abundant in human) \[[@pone.0147862.ref015], [@pone.0147862.ref016]\], are believed to effect first-phase GSIS by acting on the readily releasable pool (RRP) of predocked SGs \[[@pone.0147862.ref017]--[@pone.0147862.ref020]\]. Genetic deletion of R-type/Ca~v~2.3 suppressed only the second-phase GSIS from the mouse islets; and did not affect the early component of depolarization-induced exocytosis (corresponding to the RRP) in the β-cells \[[@pone.0147862.ref021], [@pone.0147862.ref022]\], leaving intact the late component, referred to as SG mobilization from the reserve pool, which corresponds to the newcomer SGs. This led us and others to hypothesize that predocked SGs mediating a major portion of first-phase GSIS and newcomer SGs accounting for all of second-phase GSIS are respectively mediated by L- and R-type Ca~v~s.

Of the four Syns that mediate exocytosis, Syn-1A, Syn-2 and Syn-4 are present and localized predominantly to the β-cell PM, whereas Syn-3 is more abundant in SGs \[[@pone.0147862.ref005], [@pone.0147862.ref023]--[@pone.0147862.ref025]\]. Genetic deletion of Syn-1A in mice blunted first-phase GSIS, which was attributed to loss of ability of predocked insulin SGs to undergo exocytosis, without perturbation of recruitment and fusion of newcomer SGs \[[@pone.0147862.ref005]\]. Syn-1A binding and inhibition of L-type Ca~v~ \[[@pone.0147862.ref009], [@pone.0147862.ref010]\] was demonstrated to be via the two highly conserved cysteines, Cys271 and Cys272 at its transmembrane domain \[[@pone.0147862.ref026]--[@pone.0147862.ref028]\]. In contrast, depletion of endogenous Syn-3 by RNA interference (RNAi) in INS-1 cells inhibited GSIS by impairing the recruitment and fusion of newcomer SGs affecting predominantly the second-phase GSIS, without affecting predocked SGs \[[@pone.0147862.ref023]\]. Overexpression of Syn-3 was reported to also inhibit β-cell L-type Ca~v~ \[[@pone.0147862.ref009]\]. However, it remains unclear whether endogenous Syn-3 modulates Ca~v~ channels in β-cells. Furthermore, the putative Ca~v~-interacting transmembrane cysteine residues in Syn-1A are not conserved in Syn-3. Therefore, more work is required to clarify which β-cell Ca~v~s Syn-3 acts on and the putative Ca~v~-binding domain within Syn-3.

In this work, we assessed the endogenous function of Syn-3 on β-cell Ca~v~ activity by siRNA depletion and provide detailed biochemical and functional evidence for the interactions between endogenous Syn-3 and R-type (Ca~v~2.3) and to lesser degree also L-type (Ca~v~1.2 and Ca~v~1.3) Ca~v~s.

Methods {#sec002}
=======

Cell Culture {#sec003}
------------

INS-1 832/13 cells and HEK293 cells lines were cultured as previously reported \[[@pone.0147862.ref029], [@pone.0147862.ref030]\]. INS-1 832/13 cell line (herein called INS-1) was a gift from Christopher Newgard (Duke University, Durham, North Carolina) \[[@pone.0147862.ref031]\]. Syn-3 siRNA/mCherry plasmid (Dharmacon, Chicago, IL, USA) used here we previously reported to efficiently knockdown (KD) Syn-3 expression in INS-1 cells \[[@pone.0147862.ref023]\]. A mCherry plasmid was used as control \[[@pone.0147862.ref023]\]. After the cells were transfected with these plasmids for 48 h, cellular entry of the plasmids was confirmed by the mCherry expression observed by epifluorescence imaging. These mCherry-expressing cells were subjected to electrophysiology and TIRF imaging studies.

Immunoprecipitation {#sec004}
-------------------

This was performed on INS-1 cells as previously reported \[[@pone.0147862.ref030], [@pone.0147862.ref032]\]. INS-1 cells at 80%--85% confluence were washed with PBS (37°C) and incubated for 30 min at 37°C in Krebs--Ringer HEPES buffer (KRB, in mM: 125 NaCl, 5.6 KCl, 1.28 CaCl~2~, 5 Na~2~CO~3~, 25 HEPES, pH 7.4. with 0.1% BSA) containing basal 0.8 mM glucose concentration. Cells intended for stimulation were preincubated for 30 min with 0.8 mM glucose, and then stimulated with 16.7 mM glucose plus 10 nM glucagon-like peptide (GLP)-1 for 30 min. 1 mg protein extract of cell lysates were used for each condition. Immunoprecipitation (IP) was with 2 μg Syn-1A or Syn-3 antibodies or pre-immune IgG (as control). Precipitated proteins were immunodecorated and identified using the indicated primary antibodies, which include anti-Ca~v~1.2, -Ca~v~1.3, -Ca~v~2.3, -Ca~v~2.2, -Ca~v~α~2~δ-1, -Ca~v~β3, -SNAP25, -Syn-1A and--Syn-3. All Ca~v~ subunits antibodies are from Alomone Labs (Jerusalem, Israel), and SNAP25, Syn-1A and Syn-3 are from SySy (Goettingen, Germany); the specificity of these antibodies was well characterized by these companies, which been used broadly. IP experiments on HEK293 cells transfected with Syn-1A, Syn-3, Ca~v~1.3 or Ca~v~2.3, were similar to those performed on INS-1 cells.

In Vitro Binding Assay and Western Blotting {#sec005}
-------------------------------------------

In vitro binding assays were performed according to the method we previously described \[[@pone.0147862.ref030], [@pone.0147862.ref032], [@pone.0147862.ref033]\], which also showed the specificity of the SNARE protein antibodies. Briefly, GST-Syn-1A (cytoplasmic domain a.a. 1--265), GST-Syn-3 (cytoplasmic domain a.a. 1--263) and GST (as control, 300 pM protein each, all bound to glutathione agarose beads) were incubated with HEK293 cell lysate at 4°C for 2 h with constant agitation. The beads were then washed three times with washing buffer (in mM: 20 HEPES (pH 7.4), 150 KOAC, 1 EDTA, 1 MgCl~2~; with 5% glycerol and 0.1% Triton X-100). Precipitated proteins were separated on 10% SDS-PAGE and identified with anti-Ca~v~1.3 or -Ca~v~2.3 antibody (1:200).

All of the Western blot bands were quantified using image J software (<http://rsb.info.nih.gov/ij>). We employed two approaches to quantify the 'input control' and 'co-immunoprecipitated (co-IPed)' blots. For quantification of 'input control' bands, we considered maximum intense band for each protein from each experiment as 100 and expressed other bands for that particular protein as % of maximum. For quantification of 'co-IPed' blots, we measured intensities of both 'co-IPed' and 'input control' bands that are processed in parallel. The intensity of 'co-IPed' band was then calculated as a ratio to the corresponding 'input control' band intensity and multiplied by 5 (as 'input control' is 5% of total protein used for IP) and expressed as 'percentage of recovery'.

Electrophysiology {#sec006}
-----------------

Recording pipettes were pulled from 1.5-mm borosilicate glass capillary tubes using a programmable micropipette puller. Pipettes were heat polished to a tip resistance ranging from 2 to 3 MOhm when filled with the intracellular solution. For measurement of Ca~v~ currents, barium was used as charge carrier. Pipettes were filled with the buffer containing (in mM): 120 CsCl, 20 tetraethylammonium chloride, 5 EGTA, 5 MgATP and 5 HEPES (pH 7.2 with CsOH). The external solution contained (in mM): 100 NaCl, 20 BaCl~2~, 20 tetraethylammonium chloride, 4 CsCl, 1 MgCl~2~, 10 glucose and 5 HEPES (pH 7.4 with NaOH). L-type Ca~v~ inhibitor nifedipine (10 μM), R-type Ca~v~ inhibitor SNX482 (400 nM) and N-type Ca~v~ inhibitor ω-Conotoxin GVIA (100 nM) are all from Alomone labs (Jerusalem, Israel). Cells were held at −70 mV for 2 min after formation of whole-cell mode, and currents elicited by stepped 300 or 500 milliseconds depolarizations in 10 mV increments. Recordings were conducted using an EPC10 patch clamp amplifier equipped with Pulse and X-Chart software programs (HEKA Electronik, Lambrecht, Germany).

Statistical Analysis {#sec007}
--------------------

Data are presented as mean±SEM. Statistical significance was evaluated by Student's t test or Mann-Whitney rank sum test (SigmaStat 3.11. Systat Software Inc., Chicago, IL, USA) and considered significant when P\<0.05.

Results {#sec008}
=======

Syn-3 Binds to Distinct β-cell Ca~v~s than Syn-1A {#sec009}
-------------------------------------------------

We postulated that Syn-3's actions on Ca~v~ channels \[[@pone.0147862.ref009]\] may be by direct physical binding to Ca~v~ subunits as had been demonstrated for Syn-1A \[[@pone.0147862.ref011], [@pone.0147862.ref012]\]. This was assessed with Syn-3 antibody co-immunoprecipitation of INS-1 at basal (0.8 mM glucose) and maximal stimulated conditions (16.7 mM glucose plus 10 nM GLP-1). [Fig 1A and 1B](#pone.0147862.g001){ref-type="fig"} show that Syn-3 co-precipitated Ca~v~α1 pore-forming subunits including Ca~v~1.2, Ca~v~1.3 and Ca~v~2.3, but not Ca~v~2.2. Syn-3 also brought down small amounts of auxiliary subunits α~2~δ-1 and β3. Remarkably, GLP-1/high glucose stimulation caused a large increase in the amount of Ca~v~2.3 co-precipitated (from 1.7% to 8.1%, a 4.7 fold increase; p\<0.001), a more moderate increase in Ca~v~1.2 co-precipitated (from 1.6% to 4.6%, a 2.9 fold increase; p\<0.05), and no significant increase in Ca~v~1.3 co-precipitated (1.9% to 2.0%). There was no increase in the levels of co-precipitated auxiliary subunits α~2~δ-1 and β3; and there was no detectable Ca~v~2.2 brought down. There was also an expected large increase in the amount of SNAP25 co-precipitated (from 0.9% to 7.5%, p\<0.001). These results indicate a preferential formation of the Syn-3/Ca~v~2.3 α1 complex, and the more moderate formation of the Syn-3/Ca~v~1.2 complex could explain our previous report on why Syn-3 overexpression also affected L-type Ca~v~ current \[[@pone.0147862.ref009]\].

![Syn-3 co-immunoprecipitates (IP) distinct Ca~v~s than Syn-1A in INS-1 cells.\
Syn-3 (A) and Syn-1A (C) interactions with the indicated Ca~v~α1 subunits (Ca~v~1.2, Ca~v~1.3, Ca~v~2.3 and Ca~v~2.2) and auxiliary subunits (α~2~δ-1 and β3) and SNAP25 in INS-1 cells. Densitometric analysis of Syn-3 co-IP (B) and Syn-1A co-IP (D), expressed as percent recovery of total lysate inputs (which showed equal protein loading in [S1 Fig](#pone.0147862.s001){ref-type="supplementary-material"}), shows that high glucose (16.7 mM) plus GLP-1 (10 nM) increased the association of these syntaxins with the respective Ca~v~s. Values are means±SEM, n = 3. \*p\<0.05, \*\*\*p\<0.001, NS: not significant. As control (E) shows representative blots from five separate co-IP experiments with pre-immune IgG, which did not bring down syntaxins or Ca~v~s (*left* lanes). *Righ*t lanes show the input lysates. All five experiments probed for the Ca~v~ α subunits and α~2~δ-1, whereas β3, Syn-3 and Syn-1A were probed on two blots from separate experiments.](pone.0147862.g001){#pone.0147862.g001}

Syn-1A antibody co-precipitated Ca~v~1.3, Ca~v~2.2 and Ca~v~2.3 α1 subunits ([Fig 1C](#pone.0147862.g001){ref-type="fig"}). However, only the amounts of Ca~v~1.3 (from 1.9% at basal to 15% when stimulated, a 7.8 fold increase; p\<0.001; N = 3; [Fig 1C and 1D](#pone.0147862.g001){ref-type="fig"}) and Ca~v~2.2 (from 3.6% to 9.4%; p\<0.05; N = 3; [Fig 1C and 1D](#pone.0147862.g001){ref-type="fig"}) to lesser degree increased with stimulation, whereas there was no further increase in the amount of Ca~v~2.3 co-precipitated. SNAP25 co-precipitated increased from 1.25% to 6.3% (p\<0.05; N = 3) after stimulation. The latter results confirm the previous hypothesis that Syn-1A preferentially associates with L-type Ca~v~ to form a complex exictosomes, which is functionally important in mediating exocytosis of predocked insulin SG \[[@pone.0147862.ref006], [@pone.0147862.ref007]\]. While our results support that Syn-1A could also bind R-type Ca~v~ \[[@pone.0147862.ref034]\], this complex is perhaps less important in β-cell or at least subordinate to the more abundant Syn-3-R-type Ca~v~ complex that formed. Syn-1A is known to also bind N-type Ca~v~ in neurons \[[@pone.0147862.ref035]\] that is also found in INS-1 \[[@pone.0147862.ref034]\], albeit less abundant, thus presumably less important in β-cell. As control, at maximal stimulation with high glucose plus GLP-1, preimmune IgG did not pull down the syntaxins or any of the Ca~v~ subunits ([Fig 1E](#pone.0147862.g001){ref-type="fig"}). [S1 Fig](#pone.0147862.s001){ref-type="supplementary-material"} shows the corresponding input proteins with the Syn-3 or Syn-1A IP experiments in [Fig 1](#pone.0147862.g001){ref-type="fig"} in both control and stimulated INS-1 cells.

Syn-3 Preferentially Binds Ca~v~2.3, whereas Syn-1A Preferentially Binds Ca~v~1.2 and Ca~v~1.3 {#sec010}
----------------------------------------------------------------------------------------------

The co-IP studies of endogenously interacting proteins ([Fig 1](#pone.0147862.g001){ref-type="fig"}) showed a preference of Syn-3 for R-type/Ca~v~2.3 over L-type Ca~v~s. We therefore next critically assessed whether Syn-3 vs Syn-1A do indeed preferentially bind R- and L-type Ca~v~s, respectively, by employing the HEK cell model. HEK cells, devoid of endogenous Ca~v~s and SNARE proteins, allow these proteins to be individually exogenously expressed presumably in their native conformations, unperturbed by any other proteins that might affect them or their interactions as may be the case using native β-cells ([Fig 1](#pone.0147862.g001){ref-type="fig"}).

Immunoprecipitation experiments were conducted in HEK cells expressing only Syn-3 or Syn-1A with Ca~v~1.3 or Ca~v~2.3 α1 subunits. When calculated as the percentage of protein recovery from total lysate input, Syn-1A co-precipitated Ca~v~1.3 with an average (N = 3) of 18.1±3.5% versus Syn-3 of 7.8±1.8%, which is 2.3 times higher ([Fig 2A and 2B](#pone.0147862.g002){ref-type="fig"}). In contrast, Syn-3 antibody co-precipitated more Ca~v~2.3 (6.1±0.8%) than Syn-1A antibody (2.2±0.3%), which is 2.8 times higher ([Fig 2C and 2D](#pone.0147862.g002){ref-type="fig"}). Therefore, while there is some promiscuity in the binding of Syn-1A and Syn-3 for these Ca~v~s, Syn-1A preferentially binds Ca~v~1.3 and Syn-3 preferentially binds Ca~v~2.3. This is consistent with the current thinking that while the Syn-1A-Ca~v~1.3 complex targets the PM sites of maximal Ca^2+^ influx to where predocked insulin SGs exocytose \[[@pone.0147862.ref006], [@pone.0147862.ref007]\], we further postulate that the Syn-3-Ca~v~2.3 complex likely targets the PM sites of Ca^2+^ influx where exocytosis of newcomer insulin SGs \[[@pone.0147862.ref023]\] would likely occur. This thinking is also consistent with the role of Ca~v~2.3 in second-phase GSIS \[[@pone.0147862.ref021]\].

![Syn-3 preferentially binds Ca~v~2.3 while Syn-1A preferentially binds Ca~v~1.3.\
Representative blots show HEK293 cells co-transfected with Ca~v~1.3 (A) or Ca~v~2.3 (C) with either Syn-1A or Syn-3, then subjected to co-IP with anti-Syn-1A or Syn-3 antibody. Co-precipitated proteins were identified with the indicated antibodies. Densitometric analysis of the co-precipitated Ca~v~1.3 (B) or Ca~v~2.3 (D), expressed as percent recovery of total lysate inputs. Values are means±SEM, n = 3; \*p\<0.05, \*\*p\<0.01.](pone.0147862.g002){#pone.0147862.g002}

Depletion of Endogenous Syn-3 Selectively Enhances Ca~v~ Channels Activity {#sec011}
--------------------------------------------------------------------------

We then assessed the functional consequence of Syn-3 interactions with these Ca~v~s by depletion of endogenous Syn-3. Syn-3 siRNA plasmid co-expressing mCherry was used to transfect INS-1 832/13 cells, which effectively reduced Syn-3 protein expression by \>70%, as shown in our previous report \[[@pone.0147862.ref023]\]. INS-1 cells expressing mCherry would be expected to exhibit near-total depletion of Syn-3, thus ideal for single cell analysis by electrophysiology. Whole cell Ca~v~ current recording of Syn-3-depleted INS-1 cells showed the Ca~v~ current amplitudes were increased by 46% (54.8±5.6 pA/pF; n = 11; [Fig 3A--3C](#pone.0147862.g003){ref-type="fig"}) compared to control (mCherry transfected) cells (37.4±5.5 pA/pF; p\<0.05; n = 16). L- and R-type Ca~v~s have been postulated to be the major Ca~v~s in rodents to affect first- and second-phase GSIS, respectively \[[@pone.0147862.ref017]--[@pone.0147862.ref022]\]. N-type Ca~v~ was reported to also contribute to first-phase GSIS \[[@pone.0147862.ref036]\]. We thus used selective antagonists to determine the contribution of each of these Ca~v~s to the overall Ca~v~ current density in INS-1 cells ([Fig 3D](#pone.0147862.g003){ref-type="fig"}). [Fig 3E](#pone.0147862.g003){ref-type="fig"} is the summary analysis of their Ca~v~ current densities normalized to control values, showing that amounts of Ca~v~ current blocked was 52% by nifedipine (L-type antagonist) (n = 8; p\<0.05), 31% (n = 10; p\<0.001) by SNX482 (R-type antagonist), and only 24% by ω-Conotoxin GVIA (N-type antagonist) (n = 9; p\<0.01). This suggests that more of Ca~v~ current blocked by the L- on R-type Ca~v~ antagonists, and not N-type Ca~v~ are likely attributed to the Syn-3 actions, which would be consistent with our protein-binding data (Figs [1](#pone.0147862.g001){ref-type="fig"} and [2](#pone.0147862.g002){ref-type="fig"}). To confirm that L- and R-type Ca~v~s accounted for most of the increased Ca~v~ current caused by the Syn-3 KD, we performed another set of experiments with selective blockade with nifedipine and SNX482 on Syn-3 KD cells ([Fig 3H and 3I](#pone.0147862.g003){ref-type="fig"}) and Control cells ([Fig 3F and 3G](#pone.0147862.g003){ref-type="fig"}). Nifedipine reduced the Ca~v~ current by 55%% (n = 12, p\<0.05) in Syn-3 KD cells which was slightly less than the 58% reduction (n = 14; p\<0.001) in Control cells. SNX482 reduced the Ca~v~ current by 28% (n = 6; p\<0.05) in Syn-3 KD cells which was slightly more than the 25% reduction (n = 10; p\<0.05) in Control cells.

![Depletion of Syntaxin 3 in INS-1 cells increased voltage-gated Ca^2+^ currents.\
(A) Representative traces showing Ca~v~ currents recorded in whole-cell mode from control and Syn-3 KD INS-1 cells. (B) Current-voltage relationship of Ca~v~s from control (n = 16) and Syn-3 KD (n = 11) INS-1 cells. Currents were normalized to cell capacitance to yield current density. Values are means±SEM. (C) Bar chart shows the maximum increase in current density under stimulation of 10 mV voltage. \*p\<0.05 for control vs Syn-3 KD (D) Representative Ca~v~ currents from normal INS-1 cells before and after treatment with nifedipine (10 μM Nif; n = 8), SNX482 (400 nM SNX; n = 9) or ω-Conotoxin GVIA (100 nM Conotoxin; n = 10); their summary analysis (E) of the maximum increase in current densities normalized to the percentage of control (Con). \*\*\*p\<0.001, \*\*p\<0.01 and \*p\<0.05 compared to control. We then performed another set of experiments (different from A-E) to compare the effects of nifedipine and SNX on Syn-3 KD (H and I) and Control INS-1 cells (F and G). (F) Representative Ca~v~ currents from control INS-1 cells before (control, n = 25) and after treatment with nifedipine (10 μM Nif) (n = 14) or SNX482 (400 nM SNX) (n = 6); their summary analysis (G) of the maximum increase in current densities normalized to the percentage of control (Con). \*\*\*p\<0.001; \*p\<0.05 compared to Control. (H) Representative Ca~v~ currents of Syn-3 KD INS-1 cells before (Syn-3 KD, n = 11) and after treatment with nifedipine (n = 12) or SNX482 (n = 6); and their summary analysis (I) of the maximum increase in current densities normalized as percentages of the Syn-3 KD cells. \*p\<0.05 compared to Syn-3 KD. Here, Syn-3 KD Ca~v~ currents were 148% of Control cells, similar to A and B.](pone.0147862.g003){#pone.0147862.g003}

The Functional Domain of Syn-3 that Modulates Ca~v~ Channel Activity is Different from Syn-1A {#sec012}
---------------------------------------------------------------------------------------------

It has been well studied that the putative domain of Syn-1A that modulates Ca~v~ activity is the transmembrane domain (amino acid 266--288), particularly the two vicinal cysteines (C271 and C272) \[[@pone.0147862.ref026]--[@pone.0147862.ref028]\]. Indeed, dialysis of the cytoplasmic domain of Syn-1A, GST-Syn-1A (a.a. 1--265), by patch pipette into INS-1 cells had no significant effects on the Ca~v~ current (66.2±5.1 pA/pF; n = 8) compared to GST control (51.4±9 pA/pF; n = 9; [Fig 4A--4C](#pone.0147862.g004){ref-type="fig"}). Peculiarly, the two vicinal cysteines in the Syn-1A transmembrane domain are not conserved in the transmembrane domain of Syn-3. Remarkably, dialysis of the cytoplasmic domain of Syn-3, GST-Syn-3 (a.a. 1--263) inhibited Ca~v~ current by 48% compared to control cells (26.8±5.2 pA/pF; n = 9; p\<0.05; [Fig 4A--4C](#pone.0147862.g004){ref-type="fig"}). This result suggests that the Ca~v~-interacting domains of Syn-3 and Syn-1A are different. Syn-3 shares a low 64% amino acid identity to Syn-1A \[[@pone.0147862.ref037]\], suggesting that it may be the cytoplasmic domains in Syn-3 distinct from Syn-1A that bind the Ca~v~s.

![Cytoplasmic Syn-3 domain but not cytoplasmic Syn-1A domain regulates Ca~v~ currents.\
(A) GST-Syn-3 cytoplasmic domain (a.a. 1--263) or GST-Syn-1A cytoplasmic domain (a.a. 1--265) or GST (control) was dialyzed into INS-1 cells, then Ca~v~ currents recorded. Shown are representative traces in the whole-cell mode with stimulation from −80--60 mV. (B) Current-voltage relationship of Ca~v~ channels. Currents were normalized to cell capacitance to yield current density. (C) Bar chart showing the maximum current density in INS-1 cells dialyzed with GST control (n = 9), GST-Syn-3 (n = 9), or GST-Syn-1A (n = 8). Values are means±SEM; \*p\<0.05; NS: no significant difference. (D and E) Representative blots show HEK293 cells transfected with Ca~v~1.3 (D) or Ca~v~2.3 (E) subjected to pull down with 300 pmol of GST-Syn-1A (a.a. 1--265), GST-Syn-3 (a.a. 1--263) or GST. (F) Summary analysis of four separate experiments. Data was expressed as means ± SEM; \*p\<0.05.](pone.0147862.g004){#pone.0147862.g004}

We next employed protein binding and pull down assays of the cytoplasmic domains of Syn-1A (a.a. 1--265) or Syn-3 (a.a. 1--263) with Ca~v~1.3 or Ca~v~2.3 α1 subunit expressed in HEK293 cells. As shown in [Fig 4D--4F](#pone.0147862.g004){ref-type="fig"} with transfected HEK293 cells, GST-Syn-1A (a.a. 1--265) preferentially binds to Ca~v~1.3 with an average of 25.7±7.3% versus GST-Syn-3 (a.a. 1--263) of 5.3±1.5%, which is 4.8 times higher ([Fig 4D and 4F](#pone.0147862.g004){ref-type="fig"}; n = 4; p\<0.05). In contrast, GST-Syn-3 binds more Ca~v~2.3 (20.1±4.1%) than GST-Syn-1A (8.4±1.0%), which is 2.4 times higher ([Fig 4E and 4F](#pone.0147862.g004){ref-type="fig"}; n = 4; p\<0.05). These results indicate the following. First, whereas Syn-1A cytoplasmic domain can bind Ca~v~α1 subunits, preferentially L-type Ca~v~s, it seems this binding does not significantly regulate the Ca~v~ activity. Second, the cytoplasmic domain of Syn-3 binds the Ca~v~α1 subunits, preferring R-type Ca~v~2.3, thus presumably influencing Ca~v~2.3 activity. More work will be required to elucidate the putative functional Ca~v~-binding domain(s) within the Syn-3 cytoplasmic domain.

Discussion {#sec013}
==========

Taken together, these results demonstrate that Syn-3, via its cytoplasmic domain, preferentially binds and regulates R-type/Ca~v~2.3 α1 subunit. This is consistent with Syn-3's role in mediating fusion of newcomer SGs that account for all of second-phase GSIS \[[@pone.0147862.ref023]\] and Ca~v~2.3's role in mediating second-phase GSIS in rodents \[[@pone.0147862.ref021]\]. In contrast, Syn-1A preferentially binds L-type Ca~v~1.2 and Ca~v~1.3 to direct the PM sites of Ca^2+^ influx to where fusion of predocked SGs would occur during first-phase GSIS. Nonetheless, both syntaxins are promiscuous in binding both L- and R-type Ca~v~s and could therefore potentially assist each other in regulating various Ca~v~s perhaps when either syntaxin becomes deficient. In pancreatic islets of human type-2 diabetes, Syn-1A levels are severely reduced \[[@pone.0147862.ref038]\] which may presumably affect β-cell L-type Ca~v~ function that may contribute to the reduced efficiency of exocytosis of predocked insulin SGs, with ensuing reduction to absent first phase GSIS \[[@pone.0147862.ref005]\]. An increased in Syn-3 expression might compensate for the Syn-1A deficiency, perhaps by forming complexes with L-type Ca~v~s which could affect an increase in newcomer SGs exocytosis known to also occur in first-phase GSIS \[[@pone.0147862.ref025]\]. This could rescue the reduced first-phase secretion in type-2 diabetes islets that has been attributed to a loss of fusion competence of predocked SGs \[[@pone.0147862.ref038]\].

Syn-3 on insulin SGs \[[@pone.0147862.ref023]\] likely acts to direct the recruitment of newcomer SGs to PM-bound Ca~v~2.3 by forming an excitosome complex, mimicking the actions of Syn-1A-Ca~v~1.2 and Syn-1A-Ca~v~1.3 excitosomes on predocked SGs \[[@pone.0147862.ref006], [@pone.0147862.ref007]\]. During exocytosis, we postulate that Syn-3 would dissociate from Ca~v~2.3, relieving the inhibition and allowing Ca^2+^ influx to affect fusion of the newcomer SG. Whereas both syntaxins bind these Ca~v~s, the putative functional domain of Syn-1A is its transmembrane domain \[[@pone.0147862.ref026], [@pone.0147862.ref028]\] whereas the putative functional Ca~v~-binding domain of Syn-3 is within its cytoplasmic domain. It is also possible that the syntaxin-binding domain(s) in Ca~v~2.3 \[[@pone.0147862.ref034]\] may be different from that reported for L-type Ca~v~s \[[@pone.0147862.ref006], [@pone.0147862.ref011]\], called the synprint site localized to the cytosolic II-III linker connecting the second and third transmembrane domains. Much further work is required to determine the putative interacting domains between Syn-3 and Ca~v~2.3.

Lastly, our data are consistent with newcomer SGs (containing Syn-3) being located further away from the PM-bound R-type Ca~v~2.3 but are recruited to Ca~v~2.3 upon stimulation where they undergo minimal docking time at the PM before fusion. The latter would indicate more rapid priming and a high-affinity Ca^2+^ sensor (i.e. synaptotagmins) for newcomer SGs \[[@pone.0147862.ref039]\]. Synaptotagmin 7 has been purported to be the major Ca^2+^ sensor for β-cells \[[@pone.0147862.ref040]\], but whether this synaptotagmin or another synaptotagmin is the Ca^2+^ sensor for newcomer SGs remain to be elucidated. Consistent with this thinking, R-type Ca~v~ channel has been shown to recruit synaptotagmins to the PM to form part of the excitosome \[[@pone.0147862.ref034]\]. We hope that this work will trigger more future study that will lead to the full characterization of the newcomer SG excitosome as has been worked out for the predocked SG excitosome. This is of broad importance to endocrine secretory biology, as newcomer SGs likely also account for the sustained phase of secretion in other endocrine cells. While our work with the INS-1 cell line establishes proof of concept of novel Syn-3-Ca~v~ complexes influencing Ca~v~ activity, human β-cells do not contain R-type Ca~v~, but rather employ P/Q-type Ca~v~ (Ca~v~2.1) to likely mediate second-phase GSIS and consequently newcomer SG exocytosis \[[@pone.0147862.ref041]\]. Therefore, more exciting work will be required to assess if Syn-3 might similarly form complexes with human P/Q-type Ca~v~ (Ca~v~2.1) to mediate exocytosis of newcomer SGs in human β-cells.
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###### The corresponding input proteins with the Syn-3 or Syn-1A IP experiments in [Fig 1](#pone.0147862.g001){ref-type="fig"} for control and stimulated INS-1 cells.

(TIF)
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Syn

:   syntaxin

SG

:   insulin-containing secretory granule

GSIS

:   glucose-stimulated insulin secretion

PM

:   plasma membrane

Ca~v~

:   voltage-gated calcium channels

siRNA

:   small interfering RNA

KD

:   knockdown

SNARE

:   soluble *N*-ethylmaleimide-sensitive factor attachment protein receptor

VAMP

:   vesicle-associated membrane proteins

SNAP25/23

:   synaptosomal-associated proteins of 25/23 kDa

Syt

:   synaptotagmin

RRP

:   readily releasable pool

t-

:   target-

GLP-1

:   glucagon-like peptide-1

GST

:   glutathione *S*-transferase
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